Tg Therapeutics reported $-85128000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -70630000 6.97M
Amgen AMGN:US $ 2378M 45M
Ardelyx ARDX:US $ -38636000 6.2M
Arena Pharmaceuticals ARNA:US $ -124485000 19.91M
Arrowhead Research ARWR:US $ -64883000 33.02M
Bayer BAYN:GR 1.22B 426M
Biogen BIIB:US $ 858.6M 171.5M
Corcept Therapeutics CORT:US $ 36.23M 4.29M
Curis CRIS:US $ -10048000 602K
Gilead Sciences GILD:US $ 3883M 1637M
Infinity Pharmaceuticals INFI:US -10750000 501K
Intercept Pharmaceuticals ICPT:US $ -6218000 6.73M
Johnson & Johnson JNJ:US $ 7033M 2723M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Novartis NOVN:VX 3.48B 77M
Novavax NVAX:US $ -307144000 38.68M
Ptc Therapeutics PTCT:US $ -93076000 5.42M
Puma Biotechnology PBYI:US $ -8954000 7.68M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Spectrum Pharmaceuticals SPPI:US $ -33093000 10.98M
Tg Therapeutics TGTX:US $ -85128000 7.64M
Verastem VSTM:US $ -14806000 1.14M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M